I-Corps: Quick Liquid Layout: Commercialization of Microfluidic Very Large Scale Integration Design Automation Tools

I-Corps：快速液体布局：微流控超大规模集成设计自动化工具的商业化

• 批准号: 1560596
• 负责人: Philip Brisk
• 金额: $ 5万
• 依托单位: University of California-Riverside
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-11-01 至 2017-04-30
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=1560596&HistoricalAwards=false
• 关键词: Corps; Quick; Liquid; Layout; Commercialization

This project represents an initial step toward commercialization of technologies developed under NSF Award "Design Automation for Microfluidic Large Scale Integration Laboratories-on-a-Chip." Lab-on-a-Chip (LoC) technology reduces the time and cost to perform complex biological laboratory experiments through miniaturization and automation; applications of this technology include medical diagnostics, point-of-care testing, biomedical research, water quality management, environmental monitoring, etc. The design automation software will simplify the process of LoC design, providing benefits such as reduced cost of design and testing, faster time-to-market, and lower likelihood of human error. Successful commercialization of these research efforts will enhance scientific productivity and lower the barrier-to-entry for new users of LoC technology.The goals of this project are to train the principal investigator, entrepreneurial lead, and mentor in technological entrepreneuriship, and to enable them to meet with potential customers for their technology. The scope of the project involves attending two training sessions in Washington, D.C., attending weekly webinars, and traveling to visit potential customers, including academic laboratories in the biological sciences, and companies in segments such as biotechnology, medicine, healthcare, etc. The I-Corps team members will leverage these experiences to assess commercial interest in their microfluidic design automation software along with its readiness in terms of meeting customer needs. If commercialization is successful, future users of laboratory-on-a-chip technology will be able to leverage our software to automatically design their chips, as opposed to current practice which is to manually lay out the entire architecture by hand.

该项目代表了在NSF奖“微流控大规模集成芯片设计自动化”下开发的技术商业化的第一步。“芯片实验室（LoC）技术通过小型化和自动化减少了进行复杂生物实验室实验的时间和成本;该技术的应用包括医疗诊断、即时检测、生物医学研究、水质管理、环境监测等。设计自动化软件将简化LoC设计过程，提供诸如降低设计和测试成本的益处，更快的上市时间和更低的人为错误可能性。这些研究工作的成功商业化将提高科学生产力，降低LoC技术新用户的进入障碍。该项目的目标是培训首席研究员、企业家领导和技术顾问，并使他们能够与潜在客户会面。该项目的范围包括参加在华盛顿，华盛顿特区举办的两次培训班，参加每周的网络研讨会，并前往拜访潜在客户，包括生物科学的学术实验室，以及生物技术，医药，医疗保健等领域的公司。I-Corps团队成员将利用这些经验来评估他们的微流体设计自动化软件的商业兴趣，沿着其在满足客户需求方面的准备情况。如果商业化成功，芯片实验室技术的未来用户将能够利用我们的软件自动设计他们的芯片，而不是目前手动布局整个架构的做法。

项目成果

The case for semi-automated design of microfluidic very large scale integration (mVLSI) chips

微流控超大规模集成（mVLSI）芯片半自动化设计案例

• DOI: 10.23919/date.2017.7927283
• 发表时间: 2017
• 期刊: Design Automation and Test in Europe
• 作者: McDaniel, Jeffrey;Grover, William H.;Brisk, Philip
• 通讯作者: Brisk, Philip